InCarda Therapeutics Information
Contact top employees from
InCarda Therapeutics
Summary
InCarda Therapeutics is a clinical stage drug delivery company developinng novel drugs designed for rapid, safe, and effective cardioversion of atrial fibrillation (AF). AF afflicts over 10 million p...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
1-10 employees
Specialties
Cardiovascular, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Clinical Research, Pre-Clinical Research
Founded
2009
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at InCarda Therapeutics shows a diverse range of experience levels:
6% have been with the company for less than 1 year6% for 1–2 years19% for 3–4 years38% for 5–7 years13% for 8–10 years19% have over 11 years of service at InCarda TherapeuticsContact top employees from
InCarda Therapeutics
Priscilla Propst
Clinical Research Associate
Ramakrishna Nekkanti
Executive Director, Financial Planning & Analysis
Meisa Propst
Vice President Clinical Operations
Tavita Chan Tung
Executive Assistant
Carlos Schuler
Co-founder and Consulting CSO
Matt Hansen
Consultant
Reenie McCarthy
Director
Grace Colon
President, CEO and Director
Deborah Schwartz
Senior Director Regulatory Affairs at InCarda Therapeutics
Narsi Rangachari
COO, Co-Founder and Board Member
Prashanti Madhavapeddi
Director of Research
Myles Greenberg
Chief Executive Officer
Margaret Dillon
Sr Vice President, Regulatory Affairs
Marisa Crowell
Executive Director, Commercial Strategy
Julie Rogers
Contract Clinical Trial Manager
Anna Popovici
Vice President, Human Resources
Daniela Zhang
Vice President of Quality Assurance
Alisa Crowther
Accounting Consultant
